$139.90
2.83% yesterday
NYSE, May 14, 10:10 pm CET
ISIN
US23918K1088
Symbol
DVA

DaVita HealthCare Partners Stock price

$139.90
-10.98 7.28% 1M
-14.46 9.37% 6M
-9.65 6.45% YTD
+2.89 2.11% 1Y
+40.00 40.04% 3Y
+61.76 79.04% 5Y
+58.04 70.90% 10Y
NYSE, Closing price Wed, May 14 2025
-4.08 2.83%
ISIN
US23918K1088
Symbol
DVA
Sector

Key metrics

Market capitalization $10.56b
Enterprise Value $24.21b
P/E (TTM) P/E ratio 13.85
EV/FCF (TTM) EV/FCF 13.72
EV/Sales (TTM) EV/Sales 1.87
P/S ratio (TTM) P/S ratio 0.81
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 5.11%
Revenue (TTM) Revenue $12.97b
EBIT (operating result TTM) EBIT $1.95b
Free Cash Flow (TTM) Free Cash Flow $1.76b
Cash position $597.74m
EPS (TTM) EPS $10.10
P/E forward 13.00
P/S forward 0.79
EV/Sales forward 1.80
Short interest 11.93%
Show more

Is DaVita HealthCare Partners a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

DaVita HealthCare Partners Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a DaVita HealthCare Partners forecast:

1x Buy
8%
10x Hold
83%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a DaVita HealthCare Partners forecast:

Buy
8%
Hold
83%
Sell
8%

Financial data from DaVita HealthCare Partners

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
12,969 12,969
5% 5%
100%
- Direct Costs 9,472 9,472
4% 4%
73%
3,496 3,496
8% 8%
27%
- Selling and Administrative Expenses 837 837
12% 12%
6%
- Research and Development Expense - -
-
-
2,659 2,659
7% 7%
21%
- Depreciation and Amortization 713 713
5% 5%
5%
EBIT (Operating Income) EBIT 1,946 1,946
12% 12%
15%
Net Profit 860 860
5% 5%
7%

In millions USD.

Don't miss a Thing! We will send you all news about DaVita HealthCare Partners directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DaVita HealthCare Partners Stock News

Neutral
Seeking Alpha
2 days ago
DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Andrew Mok - Barclays Christian Porter - Bank of America Dean Rosales - Wolfe Research Pito Chickering - Deutsche Bank A.J. Rice - UBS Ryan Langston - TD Cowen Operator Good evening.
Positive
Reuters
2 days ago
DaVita beat Wall Street estimates for first-quarter profit on Monday, driven by steady demand for its kidney dialysis services.
Neutral
Investopedia
2 days ago
Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.
More DaVita HealthCare Partners News

Company Profile

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Head office United States
CEO Javier Rodriguez
Employees 76,000
Founded 1994
Website www.davita.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today